An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma

Sara Nava; Marta Dossena; Simona Pogliani; Serena Pellegatta; Carlo Antozzi; Fulvio Baggi; Cinzia Gellera; Bianca Pollo; Eugenio A. Parati; Gaetano Finocchiaro; Simona Frigerio

doi:10.1371/journal.pone.0052301

Loading metrics

Open Access

Peer-reviewed

Research Article

An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma

Sara Nava ,

Contributed equally to this work with: Sara Nava, Marta Dossena

Affiliation Cell Therapy Production Unit – UPTC, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯
Marta Dossena ,

Contributed equally to this work with: Sara Nava, Marta Dossena

Affiliation Cell Therapy Production Unit – UPTC, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯
Simona Pogliani,

Affiliation Cell Therapy Production Unit – UPTC, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯
Serena Pellegatta,

Affiliation Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯
Carlo Antozzi,

Affiliation Neurology IV, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯
Fulvio Baggi,

Affiliation Neurology IV, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯
Cinzia Gellera,

Affiliation Department of Genetics of Neurodegenerative and Metabolic Diseases, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯
Bianca Pollo,

Affiliation Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯
Eugenio A. Parati,

Affiliation Cell Therapy Production Unit – UPTC, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯
Gaetano Finocchiaro,

Affiliation Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯
Simona Frigerio

* E-mail: uptc@istituto-besta.it

Affiliation Cell Therapy Production Unit – UPTC, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
⨯

An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma

Sara Nava,
Marta Dossena,
Simona Pogliani,
Serena Pellegatta,
Carlo Antozzi,
Fulvio Baggi,
Cinzia Gellera,
Bianca Pollo,
Eugenio A. Parati,
Gaetano Finocchiaro

Published: December 20, 2012
https://doi.org/10.1371/journal.pone.0052301

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Cancer immunotherapy
Is the Subject Area "Cancer immunotherapy" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Monocytes
Is the Subject Area "Monocytes" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Flow cytometry
Is the Subject Area "Flow cytometry" applicable to this article?

Thanks for your feedback.